Table 2

Percentage reticulocytes, F+ reticulocytes, and F+ cells by flow cytometry

PercentagesBaseline40 mg/kg60 mg/kg60 mg/kg + phlebotomy
Reticulocytes 
    FG-2216 treated 0.7 ± 0.2 1.8 ± 1.1 2.4 ± 0.2 3.7 ± 0.5 
    Not treated 1.6 ± 0.8 1.9 ± 0.8 2.0 ± 1.2 4.8 ± 2.0 
F+ reticulocytes 
    FG-2216 treated 5.2 ± 1.0 5.6 ± 2.9 7.6 ± 4.5* 8.9 ± 3.7 
    Not treated 0.6 ± 0.8 1.1 ± 1.5 3.0 ± 3.7 
F+ cells 
    FG-2216 treated 0.7 ± 0.2 1.8 ± 1.1 3.3 ± 1.7* 5.0 ± 1.3 
    Not treated 0.2 ± 0.1 0.3 ± 0 0.4 ± 0.3 0.9 ± 0.5 
PercentagesBaseline40 mg/kg60 mg/kg60 mg/kg + phlebotomy
Reticulocytes 
    FG-2216 treated 0.7 ± 0.2 1.8 ± 1.1 2.4 ± 0.2 3.7 ± 0.5 
    Not treated 1.6 ± 0.8 1.9 ± 0.8 2.0 ± 1.2 4.8 ± 2.0 
F+ reticulocytes 
    FG-2216 treated 5.2 ± 1.0 5.6 ± 2.9 7.6 ± 4.5* 8.9 ± 3.7 
    Not treated 0.6 ± 0.8 1.1 ± 1.5 3.0 ± 3.7 
F+ cells 
    FG-2216 treated 0.7 ± 0.2 1.8 ± 1.1 3.3 ± 1.7* 5.0 ± 1.3 
    Not treated 0.2 ± 0.1 0.3 ± 0 0.4 ± 0.3 0.9 ± 0.5 

Values at the last 2 weeks of the treatment period were averaged. The actual mean percentages (%) and standard deviations among all animals in the same treatment cohort are shown: no drug control (n = 2), 40 mg/kg (n = 3), 60 mg/kg (n = 4), and 60 mg/kg with phlebotomy (n = 4).

*

P = .1 to .05.

P < .05 when compared with control animals.

or Create an Account

Close Modal
Close Modal